Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02992041 · ClinicalTrials.gov registry record · Phase 2

Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injections for Post-Operative Pain Following Laparoscopic Colorectomy

A Phase 2 study of Post Operative Pain, sponsored by Vivozon.

Completed
Registry status
Phase 2
Development phase
69
Enrollment target
2
Study locations

NCT02992041 is a Phase 2 study of Post Operative Pain that has completed, run by Vivozon. The registered enrollment target is 69 participants, below the 235-participant average among 56 other Post Operative Pain trials with a reported enrollment target (71% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02992041, a Phase 2 study of Post Operative Pain, has completed, sponsored by Vivozon.

COMPLETED
Registry status
Phase 2
Development phase
69 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this phase 2 study is to evaluate the efficacy and safety of an analgesic drug candidate, VVZ-149 Injections. The study is designed as randomized, double-blind, parallel, placebo-controlled study.

Conditions Studied

Interventions

  • DRUG Placebo
  • DRUG VVZ-149 Injections

Study Locations (2)

Massachusetts

  • Massachusetts General Hospital - Boston
  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 69 participants
Start Date 2016-12-27
Est. Completion 2018-04-26
Phase Phase 2

Sponsor

Vivozon

5 total trials

What the Registry Record Tells You About NCT02992041

The ClinicalTrials.gov registry entry for NCT02992041 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 235-participant average among 56 other Post Operative Pain trials with a reported enrollment target (71% lower). The listed sponsor is Vivozon, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Post Operative Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT02992041 reports 2 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02992041 about?

NCT02992041 is a clinical study titled "Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injections for Post-Operative Pain Following Laparoscopic Colorectomy". The purpose of this phase 2 study is to evaluate the efficacy and safety of an analgesic drug candidate, VVZ-149 Injections. The study is designed as randomized, double-blind, parallel, placebo-controlled study.

What is the current status of trial NCT02992041?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 69 participants. The study started on 2016-12-27. Estimated completion is 2018-04-26.

What conditions does trial NCT02992041 study?

This clinical trial studies the following conditions: Post Operative Pain.

What interventions are being tested in trial NCT02992041?

The interventions under investigation include: Placebo (DRUG), VVZ-149 Injections (DRUG).

Who is sponsoring clinical trial NCT02992041?

This trial is sponsored by Vivozon, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02992041 being conducted?

This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post Operative Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.